AMGN
AMGEN INC
AMGEN INC (AMGN) has 34 SEC Form 4 filings (56 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: May 21, 2026.
Insiders have net sold $400K over the trailing 6 months.
- Industry:Drug Manufacturers - General
- CEO:Robert A. Bradway
- Employees:28,000
- HQ:Thousand Oaks, CA, US
- IPO:1983-06-17
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$400K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$200.5B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Grygiel Nancy A.First filing | SVP & CCO | Sale | 1,237 | $400K | May 6 | SEC ↗ |
Congress trading AMGN
See timeline →- DRep. Ro KhannaPurchase$1,001 - $15,0002026-06-02
- RRep. David TaylorPurchase$1,001 - $15,0002026-06-05
- RRep. Maria Elvira SalazarSale$15,001 - $50,0002026-04-17
- DSen. Mark WarnerSale$1,001 - $15,0002026-04-07
- DSen. Mark WarnerSale$1,001 - $15,0002026-04-06
- DSen. Mark WarnerSale$1,001 - $15,0002026-04-07
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
AMGEN INC is in the Healthcare sector.